Understanding and treating rare viral infections in newborns
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
This study is working to improve care and treatment options for babies born with viral infections like CMV and herpes by bringing together 28 research sites to share knowledge and find better therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915383 on NIH RePORTER |
What this research studies
This research focuses on congenital and perinatal viral infections, such as congenital cytomegalovirus (CMV) disease and neonatal herpes simplex virus (HSV) infection. The project aims to build a collaborative network of 28 study sites to enhance clinical trial readiness and improve patient care for affected infants. By leveraging long-standing partnerships and advanced data coordination, the research seeks to identify effective therapies and reduce the burden of these rare diseases. Patients may benefit from improved treatment options and better understanding of their conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation are infants under 2 years old diagnosed with congenital or perinatal viral infections.
Not a fit: Patients with viral infections not classified as congenital or perinatal may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and care for infants suffering from rare viral infections.
How similar studies have performed: Previous research has shown success in collaborative approaches to studying rare diseases, indicating potential for impactful findings in this area.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Kimberlin, David W — University of Alabama at Birmingham
- Study coordinator: Kimberlin, David W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.